NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Relief Therapeutics Holding AG (SW: RLF)

 
RLF Technical Analysis
1
As on 7th Oct 2024 RLF STOCK Price closed @ 2.95 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RLFSTOCK Price

Open 2.93 Change Price %
High 2.99 1 Day N/A N/A
Low 2.81 1 Week 0.00 0.00
Close 2.95 1 Month 0.00 0.00
Volume 119569 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
SW Switzerland Most Active Stocks
CSGN 0.82 %
CSGN 0.82 %
UBSG 26.94 %
UBSG 26.94 %
NESN 83.62 %
NESN 83.62 %
NOVN 97.73 %
NOVN 97.73 %
PRFN 0.03 50.00%
ABBN 49.03 %
 
SW Switzerland Top Gainers Stocks
PRFN 0.03 50.00%
PRFN 0.03 50.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
CASN 1.90 8.57%
SKIN 32.50 8.33%
SKIN 32.50 8.33%
GUR 1258.00 2.78%
 
SW Switzerland Top Losers Stocks
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
LINN 585.00 -7.87%
ABT 91.50 -3.68%
 
 
RLF
Daily Charts
RLF
Intraday Charts
Whats New @
Bazaartrend
RLF
Free Analysis
 
RLF Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
RLF Forecast October 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
RLF Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
RLF Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
RLF Other Details
Segment EQ
Market Capital 359058784.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RLF Address
RLF
 
RLF Latest News
 
Your Comments and Response on Relief Therapeutics Holding AG
 
RLF Business Profile
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need. The company focuses on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications is being investigated in two U.S. Phase 2b/3 clinical trials in acute respiratory deficiency due to COVID-19, as well as in Phase 2 clinical trial for the treatment of pulmonary sarcoidosis. The company is also involved in clinical development of RLF-100 for other indications in acute and chronic lung diseases. Relief Therapeutics Holding AG is based in Geneva, Switzerland. Address: BAtiment F2/F3, Geneva, Switzerland, 1202
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service